FOXC2 and cancer: According to other studies, the results are controversial as well, with one study reporting upregulation of FOXC2 in association with cancer metastasis and epithelial-mesenchymal transition [35, 36], while other study reports FOXC2 upregulation acts as a checkpoint to inhibit epithelial cell dedifferentiation [37].